Zincum Bromatum Granule (3dh-30dh) 3 Dh Tablet is a Health Canada–registered human drug (DIN 01963392) held by Homeocan Inc., containing Zincum Bromatum. Health Canada lists its status as Cancelled Post Market (status date 20 Oct 1997). Nexara Health has matched 7 registrations of Zincum Bromatum across 1 other regulated market.
Health Canada registration
| DIN | 01963392 |
|---|---|
| Brand name | Zincum Bromatum Granule (3dh-30dh) |
| Active ingredient | Zincum Bromatum |
| Strength | 3 Dh |
| Dosage form | Tablet |
| Route | Oral |
| Company | Homeocan Inc. |
| Status | Cancelled Post Market — 20 Oct 1997 |
| Class | Human |
| ATC | |
| AHFS | 92:02.00* ; See footnote |
| Regulator record | Health Canada DPD entry · Product monograph |
Zincum Bromatum registered in other markets
7 registrations of the same molecule in 1 national registry outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| United States | Zincum Bromatum | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Zincum Bromatum | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Zincum Bromatum | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Zincum Bromatum | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Zincum Bromatum | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Zincum Bromatum | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Zincum Bromatum | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC |
See every manufacturer of Zincum Bromatum worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Zincum Bromatum Granule (3dh-30dh) (DIN 01963392) marketed in Canada?
No. Health Canada lists DIN 01963392 as Cancelled Post Market as of 20 Oct 1997.
Who holds the Canadian licence for this product?
Homeocan Inc. is the company of record in the Health Canada Drug Product Database.
Is Zincum Bromatum registered outside Canada?
Yes — Nexara Health has matched 7 registrations in 1 other market (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 01963392, status date 1997-10-20; national medicine registries: FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 01963392, status date 1997-10-20; national medicine registries: FDA NDC.
Health Canada Drug Product Database (DPD), DIN 01963392, status date 1997-10-20; national medicine registries: FDA NDC. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.